A veterinary biologic for the treatment of mixed mammary tumor and mammary adenocarcinoma in dogs.
- An emulsion of mycobacterium cell wall fractions which have been modified to reduce their toxic and allergic effect but retain their antitumor activity
- Safely treats canine mammary cancer alone or in combination with surgery
- Administered by intratumoral injection, with a generalized response where untreated sites frequently undergo regression as well
- High tumor-free survival rate
- A treatment option for dogs that are poor surgical risks
- Minimizes side effects associated with chemotherapeutic treatments
- May be used safely in-clinic with no risk to clinic personnel
- An economical treatment option for your clients
- Excellent safety profile for the patient